California AACE 17th Annual Meeting and Symposium

September 8, 2017 to September 10, 2017

This program has been planned to provide pertinent scientific and clinical information to help you achieve the best solutions in the diagnosis and therapeutic management of patients presenting with endocrine disease. Attendees will obtain updates in not only common and uncommon endocrine disorders, but also newer treatment modalities.

Providing exceptional patient care requires continuing high quality education. The American Association of Clinical Endocrinologists (AACE) was founded in 1991 by a visionary group of leaders to serve as the active voice for clinical endocrinologists. The impetus behind AACE's efforts has always been quality and cost-effective patient care for those with endocrine diseases and disorders. We hope that you will find this program of great value to you in your practice.

Target Audience

Endocrinologists, advanced practice clinicians, and other healthcare professionals living in or around the state of California.

Learning Objectives

  1. Describe the current concepts regarding biology of gender identity.
  2. Discuss the roles of pubertal blockers and cross-sex hormones in the management of youth/adolescents.
  3. Explain gaps in knowledge and priorities for research in the care of transgender youth.
  4. Discuss some of the most important adrenal-related publications in the past 1 year
  5. Apply knowledge from the recent literature to case management
  6. Debate the merits of the recent advances in adrenal disease
  7. Illustrate common clinical questions with regard to adrenal and pituitary disorders
  8. Discuss novel approaches to difficult adrenal and pituitary management issues
  9. Evaluate the challenges in operating in an environment of limited information
  10. Identify the differential diagnosis of hyponatremic disorders
  11. Develop a plan for treatment to avoid overcorrection
  12. Describe the use of vaptans in the management of hyponatremia
  13. Attendees will recognize the endocrine causes of infertility
  14. Attendees will identify the appropriate testing to differentiate various causes of infertility
  15. Attendees will discuss the appropriate management for each endocrine disorder causing infertility
  16. Review recent guidelines in thyroid disease in pregnancy
  17. Describe the scientific basis of the new guidelines
  18. Enhance clinical application of the current thyroid disease in pregnancy guidelines
  19. Calculate insulin doses based on body weight and gestational age
  20. Define gestational diabetes mellitus and the diagnostic criteria based on the glucose tolerance test
  21. Identify the toxicity on hyperglycemia on the fetus including the risk of microsomia and congenital malformations
  22. Describe the protocol for labor and delivery in the diabetic patient
  23. Identify emerging therapies in osteoporosis
  24. Describe novel molecular targets in bone disease
  25. Formulate patient-specific treatment plans in fracture prevention
  26. Cite the available literature that supports the use of mind-body techniques to address diabetes-related distress in patients
  27. Identify the common nutritional deficiencies present in patients with diabetes
  28. Discuss the potential harms and benefits of the commonly used herbal supplements in the management of diabetes
  29. Compare the latest FDA-approved technologies, including hybrid closed loop insulin pumps
  30. Summarize the evidence in support of hybrid closed loop technologies
  31. Explain the pathway to fully closed loop sensor-integrated pump technologies
Additional information
Available for MOC Points?: 
No
Practice Area: 
Diabetes
Hypoglycemia
Obesity
General Endo
Course summary
Available credit: 
  • 10.25 AMA
  • 10.25 Attendance
Course opens: 
09/08/2017
Course expires: 
09/10/2018
Event starts: 
09/08/2017 - 8:00am
Event ends: 
09/10/2017 - 12:00pm
Cost:
$0.00

Friday, September 8, 2017

7:00 - 9:00 PMWelcome Reception

Saturday, September 9, 2017

7:00 - 8:00 AMContinental Breakfast
8:00 - 8:10 AMWelcoming Remarks
Diane Cheung, MD; Program Co-Chair
Jane Weinreb, MD; Program Co-Chair
8:10 - 8:20 AMPre Meeting Assessment
8:20 - 9:05 AMManagement of Transgender Youth: Current concepts and challenging cases
Stephen M. Rosenthal, MD
Objectives:
  1. Understand current guidelines for medical management of transgender youth
  2. Understand potential adverse effects of medical management of transgender youth
  3. Understand alternate approaches to current guidelines for care of transgender youth
9:05 - 9:15 AMQuestion & Answer
9:15 - 10:00 AMYear in Adrenal
William F. Young, Jr., MD, MSc, FACP, FACE
Objectives:
  1. Discuss some of the most important adrenal-related publications in the past 1 year
  2. Apply knowledge from the recent literature to case management
  3. Debate the merits of the recent advances in adrenal disease
10:00 - 10:10 AMQuestion & Answer
10:10 - 10:40 AMBreak
10:40 - 11:25 AME-mail Consults
William F. Young, Jr., MD, MSc, FACP, FACE
Objectives:
  1. Illustrate common clinical questions with regard to adrenal and pituitary disorders
  2. Discuss novel approaches to difficult adrenal and pituitary management issues
  3. Evaluate the challenges in operating in an environment of limited information
11:25 - 11:35 AMQuestion & Answer
11:35 - 11:55 AMCA AACE Business Meeting
11:55 - 1:00 PMLunch / Fellows Meeting
1:00 - 1:50 PMEnd of the California Drought, Clinical Cases of Too Much Water
Alan G. Robinson, MD
Objectives:
  1. Make a differential diagnose of hyponatremia
  2. Develop a plan for treatment to avoid over correction
  3. Understand use of vaptans
1:50 - 2:00 PMQuestion & Answer
2:00 - 5:00 PMSymposium: “Endocrine Challenges in Pregnancy
2:00 - 2:40 PMEndocrinologists Role in Infertility Management
Sidika E. Karakas, MD 
Objectives:
  1. Attendees will recognize the endocrine causes of infertility
  2. Attendees will learn the appropriate testing to differentiate various causes of infertility
  3. Attendees will learn the appropriate management for each endocrine disorder causing infertility
2:40 - 3:20 PMThyroid Disease in Pregnancy
Jonathan D. Leffert, MD, FACP, FACE, ECNU
Objectives:
  1. To review recent guidelines in thyroid disease in pregnancy
  2. To understand the scientific basis of the new guidelines
  3. To enhance clinical understanding of the current thyroid disease in pregnancy guidelines
3:20 - 3:40 PMBreak
3:40 - 4:20 PMModern Management of Diabetes and Pregnancy
Lois Jovanovic, MD, FACP, FACN, MACE
Objectives:
  1. Learn to calculate insulin doses based on body weight and gestational age
  2. Learn the definition of gestational diabetes mellitus and the diagnostic criteria based on the glucose tolerance test
  3. Learn the toxicity on hyperglycemia on the fetus including the risk of macrosomia and congenital malformations
  4. Learn the protocol for labor and delivery
4:20 - 4:50 PMSymposium Q&A / Panel Discussion
4:50 - 5:00 PMPost Meeting Assessment
5:00 - 6:00 PMReception

Sunday, September 10, 2017

7:00 - 8:00 AMContinental Breakfast
8:00 - 8:10 AMPre Meeting Assessment
8:10 - 8:50 AMNew and Emerging Therapies in Osteoporosis
Aarthi Arasu, MD
Objectives:
  1. Identify emerging therapies in osteoporosis
  2. Describe novel molecular targets in bone disease
  3. Formulate patient specific treatment plans in fracture prevention
8:50 - 9:00 AMQuestion & Answer
9:00 - 9:40 AMDiabetes Medications and Cardiovascular Outcomes: Assessing the safety
Karol E. Watson, MD, PhD, FACC
Objectives:
  1. Review the burden of cardiovascular disease in patients with diabetes
  2. Discuss current clinical recommendations for diabetes medication use in patients with cardiovascular disease
  3. Evaluate a new paradigm for diabetes medications
9:40 - 9:50 AMQuestion & Answer
9:50 - 10:05 AMBreak
10:05 - 10:45 AMIntegrative Approaches to Diabetes Care
Rashmi Mullur, MD
Objectives:
  1. Cite the available literature that supports the use of mind-body techniques to address diabetes-related distress in patients
  2. Identify the common nutritional deficiencies present in patients with diabetes
  3. discuss the potential harms and benefits of the commonly used herbal supplements in the management of diabetes
10:45 - 10:55 AMQuestion & Answer
10:55 - 11:35 AMClosing the Loop: From sensor integrated pumps to the artificial pancreas
David Ahn, MD
Objectives:
  1. Compare the latest FDA-approved technologies, including hybrid closed loop insulin pumps
  2. Summarize the evidence in support of hybrid closed loop technologies
  3. Explain the pathway toward fully closed loop sensor-integrated pump technologies
11:35 - 11:45 AMQuestion & Answer
11:45 - 12:00 PMPost Meeting Assessment
12:00 PMClosing Remarks & Adjournment
Michael Bush, MD; CA AACE President
Marina del Ray, CA
United States

David Ahn, MD

Clinical Instructor

UCLA Division of Endocrinology, Diabetes, and Metabolism

Los Angeles, CA

Aarthi Arasu, MD

Assistant Clinical Professor of Medicine

David Geffen School of Medicine at UCLA

Los Angeles, CA

Sidika E. Karakas, MD

Professor and Chief,

Division of Endocrinology, Diabetes and Metabolism

University of California, Davis

Davis, CA

Lois Jovanovic, MD, FACP, FACN, MACE

Clinical Professor of Medicine

University of Southern California - Keck School of Medicine

Adjunct Professor of Biology, Science and Chemistry

University of California - Santa Barbara
 

Jonathan D. Leffert, MD, FACP, FACE, ECNU

Managing Partner

North Texas Endocrine Center

9301 N. Central Expwy, Suite 570

Dallas, TX

Rashmi Mullur, MD

Associate Chief of Integrative Medicine

VA Greater Los Angeles Health System

Assistant Professor of Medicine

David Geffen School of Medicine at UCLA

Santa Monica, CA

Alan G. Robinson, MD

Distinguished Professor of Medicine

Associate Vice Chancellor, Senior Associate Dean

David Geffen School of Medicine at UCLA

Los Angeles, CA

Stephen M. Rosenthal, MD

Professor of Pediatrics

Division of Pediatric Endocrinology

Medical Director, Child and Adolescent Gender Center

UCSF

San Francisco, CA

Karol E. Watson, MD, PhD, FACC

Professor of Medicine/Cardiology

Co-director, UCLA Program in Preventive Cardiology

Director, UCLA Barbra Streisand Women`s Heart Health Program

Los Angeles, CA

William F. Young, Jr., MD, MSc

Professor of Medicine, Mayo Medical School

Chair, Division of Endocrinology

Mayo Clinic

Rochester, MN

The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 10.25 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 10.25 AMA
  • 10.25 Attendance

Accreditation Period

Course opens: 
09/08/2017
Course expires: 
09/10/2018

Price

Cost:
$0.00
Please login or register to take this course.